News in the Life Sciences Industry

MELBOURNE, Australia and SAN FRANCISCO, Oct. 26, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study in the United States.

SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Read more ››

RARITAN, N.J., Oct. 26, 2020 /CNW/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its new VITROS(®) SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for distribution throughout the EU. The company also filed... Read more ››

WATERFORD, Wisconsin, Oct. 27, 2020 /PRNewswire/ -- Today, Avidity Science announces significant steps in expanding its global leadership in biomedical research solutions via the acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems. These investments expand... Read more ››

MENLO PARK, Calif., Oct. 27, 2020 /PRNewswire/ -- Drawbridge Health, a healthcare technology company redefining the blood draw experience for both patients and healthcare providers, today announced a further investment from Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") as... Read more ››

SUZHOU, China and ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug... Read more ››

WASHINGTON, Oct. 26, 2020 /PRNewswire/ -- A new poll from the American College of Emergency Physicians (ACEP) and Morning Consult finds that despite the growing toll that serving on the frontlines of COVID-19 is having on emergency physicians, many are hesitant to seek mental health treatment.... Read more ››

WASHINGTON, Oct. 26, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application to evaluate Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) activator... Read more ››

CUPERTINO, Calif., Oct. 26, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will partipate in the ROTH Capital Healthcare Event, "Covid-19 Therapeutics in Development," taking place on Wednesday, October 28, 2020. The ROTH Healthcare and Biotechnology... Read more ››